- 标题
- 摘要
- 关键词
- 实验方案
- 产品
-
Prospective comparison of (4S)-4-(3-18F-fluoropropyl)-l-glutamate versus 18F-fluorodeoxyglucose PET/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study
摘要： Purpose (4S)-4-(3-18F-Fluoropropyl)-L-glutamate (FSPG) positron emission tomography (PET) reflects system xC- (xCT) expression. FSPG PET has been used to detect brain, lung, breast and liver cancer with only modest success. There is no report on the use of FSPG PET in pancreatic ductal adenocarcinoma (PDAC), presumably because of normal xCT expression in the pancreas. Nonetheless, the tissue-specific expression of xCT in the pancreas suggests that FSPG PET may be ideal for identifying metastasized PDAC. Methods The performance of FSPG in detecting PDAC metastases was compared with that of 18F-fluorodeoxyglucose (FDG) in small-animal PET studies in seven PDAC tumour-bearing mice and in prospective PET/computed tomography (CT) studies in 23 patients with tissue-confirmed PDAC of stage III or stage IV. All PET/CT results were correlated with the results of histopathology or contrast-enhanced CT (ceCT) performed 3 and 6 months later. Results In the rodent model, FSPG PET consistently found more PDAC metastases earlier than FDG PET. FSPG PET showed a trend for a higher sensitivity, specificity and diagnostic accuracy than FDG PET in detecting PDAC metastases in a patient-based analysis: 95.0%, 100.0% and 95.7%, and 90.0%, 66.7% and 90.0%, respectively. In a lesion-based analysis, FSPG PET identified significantly more PDAC metastases, especially in the liver, than FDG PET (109 vs. 95; P = 0.0001, 95% CI 4.9–14.6). The tumour-to-background ratios for FSPG and FDG uptake on positive scans were similar (FSPG 4.2 ± 4.3, FDG 3.6 ± 3.0; P = 0.44, 95% CI ?1.11 to 0.48), despite a lower tumour maximum standardized uptake value in FSPG-avid lesions (FSPG 4.2 + 2.3, FDG 7.7 + 5.7; P = 0.002, 95% CI 0.70–4.10). Because of the lower physiological activity of FSPG in the liver, FSPG PET images of the liver are more easy to interpret than FDG PET images, and therefore the use of FSPG improves the detection of liver metastasis. Conclusion FSPG PET is superior to FDG PET in detecting metastasized PDAC, especially in the liver.
关键词： FSPG,Pancreatic cancer,Positron emission tomography,Liver metastases,xC transporter system
更新于2025-11-21 11:24:58
-
Positron emission tomography/computed tomography outperforms MRI in the diagnosis of local recurrence and residue of nasopharyngeal carcinoma: An update evidence from 44 studies
摘要： Studies on nasopharyngeal carcinoma (NPC) in five electronic databases were systematically searched online from the inception to June 5, 2018. Quality of the included studies was assessed using the updated Quality Assessment of Diagnostic Accuracy Studies 2. Data of sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and the 95% confidence intervals were pooled using a bivariate random‐effect model. Forty‐four studies with 61 groups of data and totally 3369 patients were included in the qualitative and quantitative synthesis analysis. The overall estimated sensitivity and specificity of positron emission tomography/computed tomography/magnetic resonance imaging (PET‐CT/MRI) for local recurrent/residual NPC were 0.90 and 0.85, respectively. The pooled area under the curve of (AUC) of PET‐CT/MRI in the summary receiver operator characteristic curve was 0.94. Subgroup analysis showed MRI vs PET‐CT had lower sensitivity (0.83 vs 0.92) and specificity (0.78 vs 0.89). The AUCs of MRI and PET‐CT were 0.87 and 0.96, respectively. No‐cross of 95% CI was found in MRI vs PET/CT (0.87‐0.90 vs 0.94‐0.98). Meta‐regression showed PET/CT vs MRI was a potential source of heterogeneity. PET/CT and MRI both showed quite high overall ability in diagnosing local recurrent/residual NPC, but the subgroup analysis indicated PET‐CT was superior over MRI in diagnosis of local recurrence and residue of NPC after radiotherapy. The examination methods affected the heterogeneity within studies.
关键词： specificity,positron emission tomography/computed tomography,sensitivity,magnetic resonance imaging,recurrence/residue,nasopharyngeal carcinoma
更新于2025-09-23 15:23:52
-
Initial evaluation of <scp>PET</scp> / <scp>CT</scp> with <sup>18</sup> F‐ <scp>FSU</scp> ‐880 targeting prostate‐specific membrane antigen in prostate cancer patients
摘要： This first-in-man study was carried out to evaluate the safety, whole-body distribution, dose estimation, and lesion accumulation of 18F-FSU-880, a newly developed probe targeting prostate-specific membrane antigen. Six prostate cancer patients with known metastatic lesions underwent serial whole-body PET/computed tomography (CT) with 18F-FSU-880. Blood and urine were analyzed before and after PET/CT. Accumulation of 18F-FSU-880 in organs and metastatic lesions in serial PET images were evaluated by measuring the standardized uptake values. From the biodistribution data, the organ doses and whole-body effective dose were calculated using OLINDA/EXM software. 18F-FSU-880 PET/CT could be carried out without significant adverse effects. High physiological uptake was observed in the salivary/lachrymal glands and kidneys. The effective dose was calculated to be 0.921 × 10?2 mSv/MBq. Known metastatic lesions were clearly visualized with high image contrast that increased with time, except in 1 patient, whose bone metastases were well-controlled and inactive. The PET/CT with 18F-FSU-880 could be carried out safely and could clearly visualize active metastatic lesions. The present results warrant further clinical studies with a larger number of cases to verify the clinical utility of 18F-FSU-880 PET/CT in the management of prostate cancer patients.
关键词： dosimetry,prostate cancer,prostate-specific membrane antigen,positron emission tomography/computed tomography,fluorine-18
更新于2025-09-23 15:23:52
-
Development of simultaneous PET and Compton imaging using GAGG-SiPM based pixel detectors
摘要： Positron emission tomography (PET) is considered an important and powerful tool for molecular imaging and medical diagnosis with its high sensitivity. Further, single-photon emission CT (SPECT) is another important imaging modality providing different types of information in medical diagnosis. On the other hand, Compton imaging is a promising technique for future molecular imaging with multi-nuclides based on Compton scattering kinetics. In this regard, previously, we have developed gadolinium aluminum gallium garnet (GAGG)-scintillation-based PET systems and GAGG-scintillation-based Compton imaging systems for environmental applications. Here, we propose and develop a novel PET–Compton hybrid simultaneous imager based on a two-layer structure using thin scatterers and thick absorbers for multi-nuclide imaging, for e.g., simultaneous imaging of PET and SPECT tracers such as 18F-FDG and 111In, respectively. For achieving good spatial resolution of the Compton imager, the energy resolution of the utilized scintillators forms one of the most important characteristics. In this regard, GAGG is a promising scintillator because of its high light yield of over 50 000 photon/MeV and excellent energy resolution of 4% with no background radiation and moderate decay time. In this study, we present the development of a simultaneous PET–Compton detector that consists of an 8 × 8 multi-pixel photon counter/SiPM (MPPC) array individually coupled with a 2.5 × 2.5 × 9-mm3 Ce:Gd3Ga2.7Al2.3O12 scintillators (absorbers) for proof of concept of simultaneous PET and SPECT imaging. The pixel size of the MPPC is 3 mm × 3 mm, and it is operated at 55 V at room temperature. The signals from the MPPC scintillators are individually amplified and converted with a dynamic time over threshold (dTOT) circuit to record the energy and timing information. In image reconstruction, the data acquired with the use of the developed modules are classified into events of either Compton imaging or PET imaging by coincidence detection between scatterer and absorber or between absorber and absorber, respectively. The coincidence events between absorber and absorber are regarded as PET annihilation-gamma events and those between scatterer and absorber are used as Compton imaging events. In our experiment, images of 111In and 18F-FDG, which are used as multi-nuclide tracers, are acquired simultaneously using the developed detector for Compton imaging and PET imaging. We believe that our approach is a significant step forward for medical imaging and related fields.
关键词： Scintillator,Single-photon emission CT,SiPM,Positron emission tomography,Compton imaging
更新于2025-09-23 15:23:52
-
Novel method to measure the intrinsic spatial resolution in PET detectors based on monolithic crystals
摘要： The main aim of this work is to provide a method to retrieve the intrinsic spatial resolution of a gamma-ray detector block based on monolithic crystals within an assembled scanner. This method consists on a discrimination of the data using a software collimation process. The results are compared with an alternative method of separating two detector blocks far enough to produce a "virtual" source collimation due to the geometric constraints on the allowed coincidence event angles. A theoretical model has been deduced to fit the measured light distribution profiles, allowing estimating the detector intrinsic spatial resolution. The detector intrinsic spatial resolution is expected to follow a Gaussian distribution and the positron-emitter source shape, given the small size of a 22Na source with 0.25 mm in diameter, can be assumed to follow a Lorentzian profile. However, the collimation of the data modifies the source shape that is no longer a pure Lorentzian distribution. Therefore, the model is based on the convolution of a Gaussian shaped distribution (contribution of the detector) and a modified Lorentzian distribution (contribution of the collimated source profile) that takes into account the collimation effect. Three LYSO crystals geometries have been studied in the present work, namely a 10 mm thick trapezoidal monolithic block, and two rectangular monolithic blocks with thicknesses of 15 mm and 20 mm, respectively. All the blocks have size dimensions of 50 mm × 50 mm. The experimental results yielded an intrinsic detector spatial resolution of 0.64 ± 0.02 mm, 0.82 ± 0.02 and 1.07 ± 0.03 mm, for the 10 mm, 15 mm and 20 mm thick blocks, respectively, when the source was placed at the center of the detector. The detector intrinsic spatial resolution was moreover evaluated across one of the axis of each crystal. These values worsen to an average value of 0.68 ± 0.04 mm, 0.90 ± 0.14 and 1.29 ± 0.19 mm, respectively, when the whole crystal size is considered, as expected. These tests show an accurate method to determine the intrinsic spatial resolution of monolithic-based detector blocks, once assembled in the PET system.
关键词： Intrinsic spatial resolution,SiPM array,Monolithic blocks,Positron Emission Tomography,Gamma ray detectors
更新于2025-09-23 15:23:52
-
[IEEE 2017 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) - Atlanta, GA (2017.10.21-2017.10.28)] 2017 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) - Axial Fourier Rebinning for Time-of-Flight PET
摘要： Fully 3D time-of-flight (TOF) PET scanners offer the potential of substantially improved image quality in clinical PET imaging. The main challenges of 3D TOF PET imaging are the data storage with either list-mode or binned formats, and the reconstruction time using iterative algorithms. Previously, we derived the Fourier rebinning and consistency equations (FORCEs), and showed 3D TOF data can be fully characterized by two consistency equations. In this work, we present an exact Fourier rebinning for 3D TOF data based on the axial consistency equation to dramatically reduce the data storage and the reconstruction time. Starting from pre-corrected 3D TOF data, the axial Fourier rebinning algorithm estimates a 2D TOF sinogram for each transverse slice without information loss. Since the 3D TOF data are axially truncated, we provide a solution to estimate the missing portion in the oblique TOF projection data. The proposed axial Fourier rebinning for TOF data (axFRT) can take advantage of all the 3D TOF data statistics, and the rebinned 2D TOF data can then be reconstructed using any algorithms for 2D or 2.5D TOF reconstructions. The axFRT algorithm allows the axial data sets being rebinned independently, and there are tens of thousands of such data sets which can naturally take advantage of the massively parallel processors to dramatically speedup the rebinning. We show numerical simulations to demonstrate that axFRT produces accurate and unbiased rebinned sinograms even for TOF PET with large axial acceptance angle. The axFRT will be particularly useful for 3D TOF PET with large axial field of view for PET imaging applications including dynamic, whole- or total-body imaging.
关键词： image reconstruction,positron emission tomography (PET),time-of-flight,Axial Fourier rebinning
更新于2025-09-23 15:23:52
-
Current Status of Patient Radiation Exposure of Cardiac Positron Emission Tomography and Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging
摘要： BACKGROUND: Radiation exposure during nuclear cardiology procedures has received much attention and has prompted citations for radiation reduction. In 2010, the American Society of Nuclear Cardiology recommended reducing the average patient study radiation exposure to <9 mSv in 50% of studies by 2014. Cardiac positron emission tomography (PET) for myocardial perfusion imaging (MPI) has emerged within recent years, but current radiation exposure in cardiac nuclear PET laboratories is unknown. This study evaluated current reported patient radiation exposure from nuclear laboratories in the United States applying for Intersocietal Accreditation Commission accreditation for MPI using single photon emission computed tomography (SPECT) or PET. METHODS AND RESULTS: This was an analysis of nuclear cardiology studies submitted to the Intersocietal Accreditation Commission for either or both cardiac PET and SPECT accreditation. Cardiac SPECT data represented year 2015 while PET data combined years 2013 to 2015. Data was analyzed with χ2 and Mann-Whitney U tests (reported as median, 25th percentile, and 75th percentile). Reported PET MPI radiation exposure for 111 laboratories (532 patient cases) was 3.7 (3.2–4.1) mSv per study with no geographic variation. Reported SPECT MPI radiation exposure for 665 laboratories (3067 patient studies) was 12.8 (12.2–14.3) mSv. Highest radiation exposure was found in the South region. Technetium-only studies resulted in a median of 12.2 mSv per study. CONCLUSIONS: Radiation exposure from cardiac PET MPI in US laboratories applying for Intersocietal Accreditation Commission accreditation is low (111 laboratories, 3.7 mSv) and substantially lower than cardiac SPECT (665 laboratories, 12.8 mSv).
关键词： technetium,accreditation,myocardial perfusion imaging,positron emission tomography,radiation exposure
更新于2025-09-23 15:23:52
-
Improved immuno-PET imaging of HER2-positive tumors in mice: Urokinase injection-triggered clearance enhancement of <sup>64</sup> Cu-trastuzumab
摘要： Immuno-positron emission tomography (immuno-PET) is expected to improve the specificity of small chemical tracers such as 18F-fluorodeoxyglucose. Whole antibodies significantly accumulate in target molecule-expressing tumors but frequently persist too long in the blood circulation for imaging purposes. We investigated the utility of whole antibodies, 64Cu-labeled via a urokinase-substrate linker, and their exogenous urokinase-responsive cleavage to enhance clearance of immuno-PET probes from the blood and shorten the time required to develop adequate imaging contrast. Specifically, we used 64Cu-labeled trastuzumab in human epidermal growth factor receptor 2 (HER2)-positive tumor-bearing mice. 64Cu-labeled trastuzumab with a urokinase-cleavage site (64Cu-CB-TE1A1P-USL-trastuzumab) was synthesized using a bifunctional chelator incorporating a urokinase substrate peptide. Urokinase cleavage was analyzed in vitro by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and radio-gel permeation-high performance liquid chromatography. Improvements in radioisotope clearance and HER2-imaging by urokinase injection were evaluated by PET imaging and ex vivo biodistribution studies in A431 tumor-bearing mice. 64Cu-CB-TE1A1P-USL-trastuzumab was cleaved into smaller radioactive fragments by 20,000 IU/mL urokinase treatment in vitro at an efficacy of ~95%. The probe targeted HER2 in A431 tumors in mice within 24 h post-injection, and approximately two-thirds of the probe in the blood circulation was eliminated via renal clearance of radioactive fragments after three urokinase injections. Therefore, the tumor/blood ratio increased 3.0-fold. Without urokinase injection, the tumor accumulation of 64Cu-CB-TE1A1P-USL-trastuzumab slowly increased and the blood radioactivity decreased over 72 h. However, the tumor/blood ratios in mice after three urokinase injections were higher at 24 h than those in mice without injections at 72 h. The results indicate that our approach shortened the time required to develop adequate imaging contrast of immuno-PET by > 2 days. Therefore, this approach can benefit high-sensitivity imaging under lower radioactive decay conditions and can decrease patient radiation exposure. In addition, it could reduce other adverse effects of radioimmunotherapy.
关键词： immuno-positron emission tomography,cancer imaging,trastuzumab,urokinase,imaging contrast,clearance enhancement
更新于2025-09-23 15:23:52
-
Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas
摘要： Computed tomography (CT) has been used as the reference imaging technique for the initial staging of diffuse large B-cell lymphoma until recent days, when the introduction of positron emission tomography (PET)/CT imaging as a hybrid technique has become of routine use. However, the performance of both examinations is still common. The aim of this work was to compare the findings between low-dose 2-deoxy-2-(18F)fluoro-d-glucose (18F-FDG) PET/CT and full-dose contrast-enhanced CT (ceCT) in 28 patients with localized diffuse large B-cell lymphoma according to PET/CT findings, in order to avoid the performance of ceCT. For each technique, a comparison in the number of nodal and extranodal involved regions was performed. PET/CT showed more lesions than ceCT in both nodal (41 vs. 36) and extranodal localizations (16 vs. 15). Disease staging according to both techniques was concordant in 22 patients (79%) and discordant in 6 patients (21%), changing treatment management in 3 patients (11%). PET/CT determined a better staging and therapeutic approach, making the performance of an additional ceCT unnecessary.
关键词： 18F-FDG,staging,positron emission tomography/computed tomography,diffuse large B-cell lymphoma
更新于2025-09-23 15:22:29
-
Application of Fluorine-18-Deoxyglucose Positron Emission Tomography and Gallium Scan for Assessment in a Patient With Adult-Onset Still's Disease
摘要： A 53-year-old female patient suffered from pain in almost her entire body, particularly the joints. Chest computed tomography revealed multiple lymphadenopathies over cervical, mediastinal, and axillary areas. A fluorine-18-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) revealed increased FDG uptake in many lymph nodes and the spleen. Lymphoma was suspected. However, the result of a biopsy showed no malignancy, and the gallium-67 citrate scan showed no gallium-avid tumor throughout the whole body. Adult-onset Still's disease was diagnosed and the patient responded well to steroid therapy. The follow-up PET/CT six months later showed complete remission of the FDG-avid lesions seen in the previous PET/CT. Our study suggests that FDG PET/CT combined with gallium-67 scan may be helpful in diagnosing patients with adult-onset Still's disease. In addition, the use of FDG PET/CT alone may be useful for the evaluation of disease distribution, disease activity, and therapeutic response.
关键词： fluorine-18-deoxyglucose,Adult-onset Still's disease,positron emission tomography/computed tomography,gallium-67
更新于2025-09-23 15:22:29